company background image
3001

Tofflon Science and Technology Group SZSE:300171 Stock Report

Last Price

CN¥28.39

Market Cap

CN¥18.0b

7D

1.5%

1Y

-46.5%

Updated

16 Aug, 2022

Data

Company Financials +
300171 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance5/6
Financial Health6/6
Dividends4/6

300171 Stock Overview

Tofflon Science and Technology Group Co., Ltd.

Tofflon Science and Technology Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tofflon Science and Technology Group
Historical stock prices
Current Share PriceCN¥28.39
52 Week HighCN¥68.00
52 Week LowCN¥26.18
Beta0.88
1 Month Change-8.27%
3 Month Change-12.57%
1 Year Change-46.54%
3 Year Change281.59%
5 Year Change156.69%
Change since IPO154.28%

Recent News & Updates

Shareholder Returns

300171CN Medical EquipmentCN Market
7D1.5%0.04%1.3%
1Y-46.5%-26.3%-9.7%

Return vs Industry: 300171 underperformed the CN Medical Equipment industry which returned -26.3% over the past year.

Return vs Market: 300171 underperformed the CN Market which returned -9.7% over the past year.

Price Volatility

Is 300171's price volatile compared to industry and market?
300171 volatility
300171 Average Weekly Movement7.3%
Medical Equipment Industry Average Movement5.6%
Market Average Movement6.0%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 300171 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 300171's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19933,672Xiaodong Zhenghttps://www.tofflon.com

Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It offers injectables, such as auto solution preparation systems, aseptic filling lines for ampoule, vials, syringes and powders, freeze dryer and auto loading systems, barrier systems, and plastic packaging machines.

Tofflon Science and Technology Group Fundamentals Summary

How do Tofflon Science and Technology Group's earnings and revenue compare to its market cap?
300171 fundamental statistics
Market CapCN¥18.04b
Earnings (TTM)CN¥928.78m
Revenue (TTM)CN¥4.71b

19.4x

P/E Ratio

3.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
300171 income statement (TTM)
RevenueCN¥4.71b
Cost of RevenueCN¥2.62b
Gross ProfitCN¥2.09b
Other ExpensesCN¥1.16b
EarningsCN¥928.78m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.46
Gross Margin44.34%
Net Profit Margin19.71%
Debt/Equity Ratio0%

How did 300171 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

26%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 300171 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300171?

Other financial metrics that can be useful for relative valuation.

300171 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.1x
Enterprise Value/EBITDA13.6x
PEG Ratio0.8x

Price to Earnings Ratio vs Peers

How does 300171's PE Ratio compare to its peers?

300171 PE Ratio vs Peers
The above table shows the PE ratio for 300171 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average47.3x
300482 Guangzhou Wondfo BiotechLtd
11.7x-0.8%CN¥16.2b
002901 Double Medical Technology
23.3x31.5%CN¥15.3b
300869 Contec Medical SystemsLtd
33.7xn/aCN¥10.5b
300298 Sinocare
120.6x30.6%CN¥15.4b
300171 Tofflon Science and Technology Group
19.4x25.8%CN¥18.0b

Price-To-Earnings vs Peers: 300171 is good value based on its Price-To-Earnings Ratio (19.4x) compared to the peer average (47.3x).


Price to Earnings Ratio vs Industry

How does 300171's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

Price-To-Earnings vs Industry: 300171 is good value based on its Price-To-Earnings Ratio (19.4x) compared to the CN Medical Equipment industry average (32.9x)


Price to Earnings Ratio vs Fair Ratio

What is 300171's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300171 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.4x
Fair PE Ratio32.8x

Price-To-Earnings vs Fair Ratio: 300171 is good value based on its Price-To-Earnings Ratio (19.4x) compared to the estimated Fair Price-To-Earnings Ratio (32.8x).


Share Price vs Fair Value

What is the Fair Price of 300171 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300171 (CN¥28.39) is trading above our estimate of fair value (CN¥9.3)

Significantly Below Fair Value: 300171 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Tofflon Science and Technology Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


25.8%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300171's forecast earnings growth (25.8% per year) is above the savings rate (3.2%).

Earnings vs Market: 300171's earnings (25.8% per year) are forecast to grow faster than the CN market (24.6% per year).

High Growth Earnings: 300171's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300171's revenue (25.6% per year) is forecast to grow faster than the CN market (17.8% per year).

High Growth Revenue: 300171's revenue (25.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 300171's Return on Equity is forecast to be low in 3 years time (19.7%).


Discover growth companies

Past Performance

How has Tofflon Science and Technology Group performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


48.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 300171 has a high level of non-cash earnings.

Growing Profit Margin: 300171's current net profit margins (19.7%) are higher than last year (18%).


Past Earnings Growth Analysis

Earnings Trend: 300171's earnings have grown significantly by 48.6% per year over the past 5 years.

Accelerating Growth: 300171's earnings growth over the past year (76.3%) exceeds its 5-year average (48.6% per year).

Earnings vs Industry: 300171 earnings growth over the past year (76.3%) exceeded the Medical Equipment industry 9.2%.


Return on Equity

High ROE: 300171's Return on Equity (20.8%) is considered high.


Discover strong past performing companies

Financial Health

How is Tofflon Science and Technology Group's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 300171's short term assets (CN¥8.7B) exceed its short term liabilities (CN¥5.3B).

Long Term Liabilities: 300171's short term assets (CN¥8.7B) exceed its long term liabilities (CN¥108.8M).


Debt to Equity History and Analysis

Debt Level: 300171 is debt free.

Reducing Debt: 300171 has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.

Debt Coverage: 300171 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 300171 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is Tofflon Science and Technology Group current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


1.36%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 300171's dividend (1.36%) is higher than the bottom 25% of dividend payers in the CN market (0.45%).

High Dividend: 300171's dividend (1.36%) is low compared to the top 25% of dividend payers in the CN market (1.88%).


Stability and Growth of Payments

Stable Dividend: 300171's dividend payments have been volatile in the past 10 years.

Growing Dividend: 300171's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (26%), 300171's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (57.5%), 300171's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

8.4yrs

Average management tenure


CEO

Xiaodong Zheng (58 yo)

8.42yrs

Tenure

CN¥271,200

Compensation

Mr. Xiao Dong Zheng has been Chairman and General Manager at Tofflon Science and Technology Group Co., Ltd. since March 18, 2014. Mr. Zheng served as General manager of Shanghai Tofflon Science and Technol...


Leadership Team

Experienced Management: 300171's management team is seasoned and experienced (8.4 years average tenure).


Board Members

Experienced Board: 300171's board of directors are considered experienced (8.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Tofflon Science and Technology Group Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Tofflon Science and Technology Group Co., Ltd.
  • Ticker: 300171
  • Exchange: SZSE
  • Founded: 1993
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: CN¥18.039b
  • Shares outstanding: 635.42m
  • Website: https://www.tofflon.com

Number of Employees


Location

  • Tofflon Science and Technology Group Co., Ltd.
  • 1509, Duhui Road
  • Shanghai
  • 201108
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/16 00:00
End of Day Share Price2022/08/16 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.